Matthew R Hughes,Emina H Huang
Matthew R Hughes
Advances in molecular biology have defined the molecular basis for colorectal cancer (CRC). Though only a fraction of CRC has been determined to have a hereditary component, the discovery of genetic alterations in these clinical syndromes h...
CLINICAL MANAGEMENT OF FAMILIES WITH HEREDITARY COLORECTAL CANCER SYNDROMES [0.03%]
林奇综合征等遗传性结直肠癌家系的临床管理
Monica Dandapani,Elena M Stoffel
Monica Dandapani
Hereditary colorectal cancer syndromes can be associated with a lifetime risk of CRC of >70% in the absence of specialized surveillance. Diagnosing a genetic predisposition to cancer allows clinicians to tailor cancer prevention strategies ...
Yu-Ning Wong
Yu-Ning Wong
Improvements in translational research have led to improved survival in patients with both localized and metastatic colorectal cancer. However, these benefits come at high costs, and the introduction of six new agents since 1996 for colorec...
Predictive Factors for Response and Toxicity in Chemotherapy: Pharmacogenomics [0.03%]
化疗反应和毒性的预测因素：药物基因组学
Hanna K Sanoff,Howard L McLeod
Hanna K Sanoff
Umar Mahmood,Rabi Upadhyay
Umar Mahmood